Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 879.5 JPY -0.93%
Market Cap: 658.7B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rohto Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Pre-Tax Income
ÂĄ37.6B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
12%
Shiseido Co Ltd
TSE:4911
Pre-Tax Income
ÂĄ19.9B
CAGR 3-Years
N/A
CAGR 5-Years
-27%
CAGR 10-Years
-8%
Kao Corp
TSE:4452
Pre-Tax Income
ÂĄ113.3B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Kose Corp
TSE:4922
Pre-Tax Income
ÂĄ17.4B
CAGR 3-Years
-10%
CAGR 5-Years
-19%
CAGR 10-Years
-2%
F
Fancl Corp
TSE:4921
Pre-Tax Income
ÂĄ10.4B
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
12%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Pre-Tax Income
ÂĄ18.7B
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
0%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
656.9B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 347.52 JPY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
37.6B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Pre-Tax Income amounts to 37.6B JPY.

What is Rohto Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
12%

Over the last year, the Pre-Tax Income growth was -4%. The average annual Pre-Tax Income growth rates for Rohto Pharmaceutical Co Ltd have been 9% over the past three years , 18% over the past five years , and 12% over the past ten years .

Back to Top